Bone MicroArchitecture in Acromegaly

Conditions:   Acromegaly;   Osteoporosis Risk Intervention:   Drug: Pegvisomant Sponsors:   Columbia University;   Pfizer Recruiting - verified July 2017

Source: ClinicalTrials.gov - July 13, 2017 Category: Research Source Type: clinical trials